Shenzhou Cell announcement, subsidiary SCTB41 of the holding company has obtained the drug clinical trial approval notice.
神州细胞：控股子公司产品SCTB41获得药物临床试验批准通知书
Shenzhou Cell: Subsidiary SCTB41 of the holding company has obtained the drug clinical trial approval notice.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated